Effect of lipoteichoic acid on dermal vascular permeability in mice

Journal of Pharmacology and Experimental Therapeutics

Volumn 294, Issue 1, 2000, Pages 280-286

  Wada, Keiji ^a   Fujii, Emiko ^a   Ishida, Hiroyasu ^a   Yoshioka, Toshimasa ^a   Muraki, Takamura ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

3 BROMO 5 [N PHENYL N [2 [[2 (1,2,3,4 TETRAHYDRO 2 ISOQUINOLYLCARBONYLOXY)ETHYL]CARBAMOYL]ETHYL]CARBAMOYL] 1 PROPYLPYRIDINIUM NITRATE; 6 ANILINO 5,8 QUINOLINEQUINONE; AMINOGUANIDINE; ANTIBODY; APAFANT; BEPAFANT; CORTICOSTERONE; CYCLOOXYGENASE 2; DIPHENHYDRAMINE; DYE; GUANYLATE CYCLASE; HISTAMINE; ICOSANOID; INDOMETACIN; INTERLEUKIN 1ALPHA; LIPOPOLYSACCHARIDE; LIPOTEICHOIC ACID; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; PROSTAGLANDIN E2; RANITIDINE; THIOPERAMIDE; THROMBOCYTE ACTIVATING FACTOR; THROMBOCYTE ACTIVATING FACTOR ANTAGONIST; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL PERMEABILITY; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFECT; DRUG MECHANISM; DRUG TOLERANCE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SKIN BLOOD VESSEL;

ANIMALS; CAPILLARY PERMEABILITY; INTERLEUKIN-1; LIPOPOLYSACCHARIDES; MALE; MICE; MICE, INBRED C57BL; NITRIC OXIDE; NITROBENZENES; SKIN; SULFONAMIDES; TEICHOIC ACIDS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0033933761     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Abate A, Kengatharan M, Ruetten H, Hirschelmann R, Thiemermann C and Vane JR (1996) Induction of cyclooxygenase-2 by lipoteichoic acid in bovine endothelial cells involves the activation factor NF-κB. Br J Pharmacol 117 (Suppl):239P.
2. Bhakdi S, Klonisch T, Nuber P and Fischer W (1991) Stimulation of monokine production by lipoteichoic acids. Infect Immun 59:4614-4620.
3. Bhattacharyya DK, Lecomte M, Dunn J, Morgans DJ and Smith WL (1995) Selective inhibition of prostaglandin endoperoxide synthase-1 (cyclooxygenase-1) by valerylsalicylic acid. Arch Biochem Biophys 317:19-24.
4. Bone RC (1994) Gram-positive organisms and sepsis. Arch Intern Med 154:26-34.
5. Buchanan JE and Phillis JW (1993) The role of nitric oxide in the regulation of cerebral blood flow. Brain Res 610:248-255.
6. De Kimpe SJ, Hunter ML, Bryant CE, Thiemermann C and Vane JR (1995a) Delayed circulatory failure due to the induction of nitric oxide synthase by lipoteichoic acid from Staphylococcus aureus in anaesthetized rats. Br J Pharmacol 114:1317-1323.
7. De Kimpe SJ, Thiemermann C and Vane JR (1995b) Role for intracellular platelet-activating factor in the circulatory failure in a model of Gram-positive shock. Br J Pharmacol 116:3191-3198.
8. DeWitt DL, Meade EA and Smith WL (1993) PGH synthase isoenzyme selectivity: The potential for safer nonsteroidal anti-inflammatory drug. Am J Med 95:40S-44S.
9. Evans GF and Zuckerman SH (1991) Glucocorticoid-dependent and -independent mechanisms involved in lipopolysaccharide tolerance. Eur J Immunol 21:1973-1979.
10. Fujii E, Irie K, Ogawa A, Ohba K and Muraki T (1996a) Role of nitric oxide and prostaglandins in lipopolysaccharide-induced increase in vascular permeability in mouse skin. Eur J Pharmacol 297:257-263.
11. Fujii E, Irie K, Uchida Y, Tsukahara F and Muraki T (1994) Possible role of nitric oxide in 5-hydroxytryptamine-induced increase in vascular permeability in mouse skin. Naunyn-Schmiedeberg's Arch Pharmacol 350:361-364.
12. Fujii E, Irie K, Uchida Y, Tsukahara F, Ohba K, Ogawa A and Muraki T (1996b) Tolerance to lipopolysaccharide-induced increase in vascular permeability in mouse skin. Eur J Pharmacol 313:129-134.
13. Fujii E, Wada K, Irie K and Muraki T (1997) Changes in vascular permeability elicited by lipoteichoic acid (LTA) and lipopolysaccharide (LPS) in mouse skin. Jpn J Pharmacol 73 (Suppl 1):146P.
14. Gierse JK, Hauser SD, Creely DP, Koboldt C, Rangwala SH, Isakson PC and Seibert K (1995) Expression and selective inhibition of the constitutive and inducible forms of human cyclo-oxygenase. Biochem J 305:479-484.
15. Issekutz AC and Bhimji S (1982) Role for endotoxin in the leukocyte infiltration accompanying Escherichia coli inflammation. Infect Immun 36:558-566.
16. Iuvone T, D'Acquisto F, Van Osselaser N, Di Rosa M, Carnuccio R and Herman AG (1998) Evidence that inducible nitric oxide synthase is involved in LPS-induced plasma leakage in rat skin through the activation of nuclear factor-κB. Br J Pharmacol 123:1325-1330.
17. Johnson JL, Wimsatt J, Buckel SD, Dyer RD and Maddipati KR (1995) Purification and characterization of prostaglandin H synthase-2 from sheep placental cotyledons. Arch Biochem Biophys 324:26-34.
18. Kengatharan KM, De Kimpe SJ, Robson C, Foster SJ and Thiemermann C (1998) Mechanism of gram-positive shock: Identification of peptidoglycan and lipoteichoic acid moieties essential in the induction of nitric oxide synthase, shock and multiple organ failure. J Exp Med 188:305-315.
19. Kengatharan KM, De Kimpe SJ and Thiemermann C (1996) Role of nitric oxide in the circulatory failure and organ injury in a rodent model of gram-positive shock. Br J Pharmacol 119:1411-1421.
20. Kopaniak MM, Issekutz AC and Movat HZ (1980) Kinetics of acute inflammation induced by E. coli in rabbits: Quantitation of blood flow, enhanced vascular permeability, hemorrhage and leukocyte accumulation. Am J Pathol 98:485-498.
21. Langenbach R, Morham SG, Tiano HF, Loftin CD, Ghanayem BI, Chulada PC, Mahler JF, Lee CA, Goulding EH, Kluckman KD, Kim HS and Smithies O (1995) Prostaglandin synthase 1 gene disruption in mice reduces arachidonic acid-induced inflammation and indomethacin-induced gastric ulceration. Cell 83:483-492.
22. MacMicking JD, Nathan C, Hom G, Chartain N, Fletcher DS, Trumbauer M, Stevens K, Xie Q, Sokol K, Hutchinson N, Chen H and Mudgett JS (1995) Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase. Cell 81:641-650.
23. McCuskey RS, Urbaschek R and Urbaschek B (1996) The microcirculation during endotoxemia. Cardiovasc Res 32:752-763.
24. Muraki T, Fujii E, Okada M, Horikawa H, Irie K and Ohba K (1996) Effect of S-ethylisothiourea, a putative inhibitor of inducible nitric oxide synthase, on mouse skin vascular permeability. Jpn J Pharmacol 70:269-271.
25. Murphy K, Haudek SB, Thompson M and Giroir BP (1998) Molecular biology of septic shock. New Horiz 6:181-193.
26. Nissen D, Pedersen LJ, Skov PS, Vejlsgaard GL, Poulsen LK, Jarløv JO, Karlsmark T and Nolte H (1997) IgE-binding components of staphylococcal enterotoxins in patients with atopic dermatitis. Ann Allergy Asthma Immunol 79:403-408.
27. Ognibene FP (1997) Pathogenesis and innovative treatment of septic shock. Adv Int Med 42:313-338.
28. Rees DD, Cellek S, Palmer RMJ and Moncada S (1990) Dexamethasone prevents the induction by endotoxin of a nitric oxide synthase and the associated effects on vascular tone: An insight into endotoxin shock. Biochem Biophys Res Commun 173:541-547.
29. Schwandner R, Dziarski R, Wesche H, Rothe M and Kirschning CJ (1999) Peptidoglycan- and lipoteichoic acid-induced cell activation is mediated by Toll-like receptor 2. J Biol Chem 274:17406-17409.
30. Shukovski L and Tsafriri A (1994) The involvement of nitric oxide in the ovulatory process in the rat. Endocrinology 135:2287-2290.
31. Smith CJ, Zhang Y, Koboldt CM, Muhammad J, Zweifel BS, Shaffer A, Talley JJ, Masferrer JL, Seibert K and Isakson PC (1998) Pharmacological analysis of cyclooxygenase-1 in inflammation. Proc Natl Acad Sci USA 95:13313-13318.
32. Szabó C, Thiemermann C, Wu C-C, Perretti M and Vane JR (1994) Attenuation of the induction of nitric oxide synthase by endogenous glucocorticoids accounts for endotoxin tolerance in vivo. Proc Natl Acad Sci USA 91:271-275.
33. Takada H, Kawabata Y, Arakaki R, Kusumoto S, Fukase K, Suda Y, Yoshimura T, Kokeguchi S, Kato K, Komuro T, Tanaka N, Saito M, Yoshida T, Sato M and Kotani S (1995) Molecular and structural requirements of a lipoteichoic acid from Entercoccus hirae ATCC 9790 for cytokine-inducing, antitumor, and antigenic activities. Infect Immun 63:57-65.
34. Terashita Z, Kawamura M, Takatani M, Tsushima S, Imura Y and Nishikawa K (1992) Beneficial effects of TCV-309, a novel potent and selective platelet activating factor antagonist in endotoxin and anaphylactic shock in rodents. J Pharmacol Exp Ther 260:748-755.
35. Utsunomiya I, Nagai S and Oh-ishi S (1994) Differential effects of indomethacin and dexamethasone on cytokine production in carrageenin-induced rat pleurisy. Eur J Pharmacol 252:213-218.
36. Wakabayashi G, Gelfand JA, Jung WK, Connolly RJ, Burke JF and Dinarello CA (1991) Staphylococcus epidermidis induces complement activation, tumor necrosis factor and interleukin-1, a shock-like state and tissue injury in rabbits without endotoxemia. J Clin Invest 87:1925-1935.
37. Yoshimura A, Lien E, Ingalls RR, Tuomanen E, Dziarski R and Golenbock D (1999) Cutting edge: Recognition of Gram-positive bacterial cell wall components by the innate immune system occurs via Toll-like receptor 2. J Immunol 163:1-5.
38. Zanetti G, Baumgartner JD and Glauser MP (1997) Sepsis and septic shock. Schweiz Med Wochenschr 127:489-499.
39. Zhang FX, Kirschning CJ, Mancinelli R, Xu XP, Jin Y, Faure E, Mantovani A, Rothe M, Muzio M and Arditi M (1999) Bacterial lipopolysaccharide activates nuclear factor-κB through interleukin-1 signaling mediators in cultured human dermal endothelial cells and mononuclear phagocytes. J Biol Chem 274:7611-7614.
40. Ziegler-Heitbrock HWL (1995) Molecular mechanism in tolerance to lipopolysaccharide. J Inflamm 45:13-26.